|
|
| (11) | Number of the document | C 1896065 |
| (68) | Number of the document | 1896065 |
| (21) | Application number for Supplementary Protection Certificate | PA 2012 019 |
| (22) | Date of filing the application | 2012-10-16 |
| (41) | Date of publication of the application | 2012-11-26 |
| Date of publication of SPC | 2013-08-26 | |
| (24) | Date of coming into effect of SPC | 2026-06-24 |
| (71) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/12/767/001, 2012-04-20 EU/1/12/767/002, 2012-04-20 EU/1/12/767/003, 2012-04-20 EU/1/12/767/004, 2012-04-20 EU/1/12/767/005, 2012 04 20 EU/1/12/767/006, 2012 04 20 EU/1/12/767/007, 2012-04-20 |
| (94) | 2027-04-25 |
| (95) | Neisseria meningitidis grupės A polisacharidas, konjuguotas su baltymo nešikliu, naudojant karbodiimido kondensavimo reakcijas |
| Request filed | SPC extension granted until | Request refused | |
| 2024-08-09 | 2027-10-25 |
| SPC term extension granted |